neopterin; D-(+)-Neopterin; D-Neopterin; D-erythro-Neopterin; 2009-64-5; L-Neopterin; 6-D-erythro-Neopterin; (D)-(+)-Neopterin; 9PLD60N7SO; 2-AMINO-6-((1S,2R)-1,2,3-TRIHYDROXYPROPYL)PTERIDIN-4(3H)-ONE; 6-(D-erythro-1,2,3-Trihydroxypropyl)pterin; [S-(R*,S*)]-2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one; (+)-Neopterin; Neopterin D-erythro-form; UNII-9PLD60N7SO; 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-1H-pteridin-4-one; 4(3H)-Pteridinone, 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-; (S-(R*,S*))-2-Amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one; 4(3H)-PTERIDINONE, 2-AMINO-6-((1S,2R)-1,2,3-TRIHYDROXYPROPYL)-; EINECS 217-924-7; 1,2,3-Proanetriol; NEOPTERIN [MI]; (1S,2R)-1-(2-amino-4-hydroxypteridin-6-yl)propane-1,2,3-triol; SCHEMBL59519; [S-(R*,S*)]-2-Amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-on; [S-(R*,S*)]-2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridine-4-one; 2-Amino-4-hydroxy-6-(1,2,3-trihydroxypropyl)pteridine; DTXSID90862811; 2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-4(3H)-pteridinone; ZINC12428336; 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-3,4-dihydropteridin-4-one; AKOS024285557; AKOS024458275; NEOPTERIN D-ERYTHRO-FORM [MI]; CS-W020795; DB15050; HY-W040055; SMP1_000327; AS-56644; (D-erythro-1,2,3-trihydroxypropyl)-pterin; C05926; Q908292; D-(+)-Neopterin, >=97.5% (sum of enantiomers, HPLC); 2-Amino-6-((1S,2R)-1,2,3-trihydroxypropyl-4(8H)-pteridone; 4(8H)-pteridinone, 2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-; (-)-2-Amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]pteridine-4(1H)-one; 2-AMINO-6-[(1S,2R)-1,2,3-TRIHYDROXYPROPYL]-3H-PTERIDIN-4-ONE